Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT03443232
Eligibility Criteria:
Inclusion Criteria:Persistent
* Persistent AF is defined as AF that persists without interruption for 7 days (electrocardiogram data or Holter), atrial fibrillation cannot be prevented in patients who orally take class I and III antiarrhythmic drugs, and patient age is \<80 years.
Exclusion Criteria:
* •left ventricular dysfunction
* atrial thrombosis
* valvular heart disease
* hyperthyroidism
* patients who underwent prosthetic heart valve replacement
* patients with previous history of atrial fibrillation ablation
* pregnant women
* patients with existing liver and kidney disease
* malignant tumors
* hematological system diseases
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
80 Years
Study:
NCT03443232
Study Brief:
Protocol Section:
NCT03443232